Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: Further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP)

Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants

Barbara Schmidt, Peter G. Davis, Diane Moddemann et al. · New England Journal of Medicine · 2001 · 717 citations · Full text

Pharmacy, Pediatrics, Pharmacology +17

Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease

Mario A. Rojas, Álvaro González, Eduardo Bancalari et al. · The Journal of Pediatrics · 1995 · 477 citations

Public Health, Child Health, Pediatrics +12

Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants

Diane Marshall, Milton Kotelchuck, Thomas E. Young et al. · PEDIATRICS · 1999 · 277 citations

Public Health, Child Health, Pediatrics +17

Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus

Elizabeth R. Brown · The Journal of Pediatrics · 1979 · 194 citations

Medicine, Clinical Sciences, Pediatrics +14

Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome

Bart Van Overmeire, Hilde Van de Broek, Paul Van Laer et al. · The Journal of Pediatrics · 2001 · 156 citations

Medicine, Pediatrics, Pharmacotherapy +17